Peptides that specifically bind HGF receptor (CMET) and uses...

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C530S333000, C514S001100, C424S001690

Reexamination Certificate

active

08044175

ABSTRACT:
A polypeptide or multimeric polypeptide construct having the ability to bind to cMet or a complex comprising cMet and HGF, and methods for use are disclosed.

REFERENCES:
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5316921 (1994-05-01), Godowski et al.
patent: 5547856 (1996-08-01), Godowski et al.
patent: 5686292 (1997-11-01), Schwall et al.
patent: 5707624 (1998-01-01), Nickoloff et al.
patent: 5766860 (1998-06-01), Terman et al.
patent: 5769080 (1998-06-01), Unger et al.
patent: 5773024 (1998-06-01), Unger et al.
patent: 5871959 (1999-02-01), Rong et al.
patent: 5876973 (1999-03-01), Marchionni
patent: 5877289 (1999-03-01), Thorpe et al.
patent: 5935820 (1999-08-01), Hu et al.
patent: 6051230 (2000-04-01), Thorpe et al.
patent: 6071495 (2000-06-01), Unger et al.
patent: 6146657 (2000-11-01), Unger et al.
patent: 6204011 (2001-03-01), Kendall et al.
patent: 6207152 (2001-03-01), Schwall et al.
patent: 6221839 (2001-04-01), Alitalo et al.
patent: 6245530 (2001-06-01), Alitalo et al.
patent: 6261535 (2001-07-01), Thorpe et al.
patent: 6261537 (2001-07-01), Klaveness et al.
patent: 6264917 (2001-07-01), Klaveness et al.
patent: 6331289 (2001-12-01), Klaveness et al.
patent: 6359115 (2002-03-01), Kendall et al.
patent: 6361946 (2002-03-01), Alitalo et al.
patent: 6403088 (2002-06-01), Alitalo et al.
patent: 6451764 (2002-09-01), Lee et al.
patent: 6521211 (2003-02-01), Unger et al.
patent: 6576608 (2003-06-01), Lee et al.
patent: 6645933 (2003-11-01), Alitalo et al.
patent: 6710165 (2004-03-01), Lee et al.
patent: 7199100 (2007-04-01), Betz et al.
patent: 2002/0058619 (2002-05-01), Tchistiakova et al.
patent: 2002/0065218 (2002-05-01), Achen et al.
patent: 2002/0068697 (2002-06-01), Tournaire et al.
patent: 2002/0086013 (2002-07-01), King
patent: 2002/0091082 (2002-07-01), Aiello
patent: 2002/0102260 (2002-08-01), Achen et al.
patent: 2002/0136721 (2002-09-01), Schwall et al.
patent: 2003/0082103 (2003-05-01), Wartchow et al.
patent: 2003/0091567 (2003-05-01), Alitalo et al.
patent: 2004/0018974 (2004-01-01), Arbogast et al.
patent: 0536350 (1992-09-01), None
patent: 1166798 (2002-01-01), None
patent: 1166799 (2002-01-01), None
patent: 666868 (2002-04-01), None
patent: 1238986 (2002-09-01), None
patent: 1261370 (2002-12-01), None
patent: 1268760 (2003-01-01), None
patent: 1278771 (2003-01-01), None
patent: 1292335 (2003-03-01), None
patent: 848755 (2003-06-01), None
patent: 1259248 (2004-12-01), None
patent: 11-506327 (1999-06-01), None
patent: 2002-330772 (2002-11-01), None
patent: 3398382 (2003-04-01), None
patent: WO 94/10202 (1994-05-01), None
patent: WO 96/38557 (1996-12-01), None
patent: WO 96/40285 (1996-12-01), None
patent: WO 97/17442 (1997-05-01), None
patent: WO 98/18498 (1998-05-01), None
patent: WO 98/18501 (1998-05-01), None
patent: WO 98/47541 (1998-10-01), None
patent: WO 99/29861 (1999-06-01), None
patent: WO 99/40947 (1999-08-01), None
patent: WO 99/58162 (1999-11-01), None
patent: WO 00/27414 (2000-05-01), None
patent: WO 00/45856 (2000-08-01), None
patent: WO 01/16135 (2001-03-01), None
patent: WO 01/42284 (2001-06-01), None
patent: WO 01/54723 (2001-08-01), None
patent: WO 01/62942 (2001-08-01), None
patent: WO 01/64235 (2001-08-01), None
patent: WO 01/70268 (2001-09-01), None
patent: WO 01/70945 (2001-09-01), None
patent: WO 01/82870 (2001-11-01), None
patent: WO 01/83693 (2001-11-01), None
patent: WO 01/97850 (2001-12-01), None
patent: WO 02/07747 (2002-01-01), None
patent: WO 02/28895 (2002-04-01), None
patent: WO 02/057299 (2002-07-01), None
patent: WO 02/060950 (2002-08-01), None
patent: WO 02/083849 (2002-10-01), None
patent: WO 03/000842 (2003-01-01), None
patent: WO 03/000844 (2003-01-01), None
patent: WO 03/028643 (2003-04-01), None
patent: WO 03/094617 (2003-11-01), None
Bardelli et al., A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth. J Biol Chem. Oct. 8, 1999;274(41):29274-81.
Date et al., HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. Dec. 22, 1997;420(1):1-6.
Hanessian et al., Synthesis of a Versatile Peptidomimetic Scaffold. Methods in Molecular Medicine 23: 161-174, 1999.
Hart et al., Cyclophilin Inhibition by a (Z)-Alkene cis-Proline Mimic. J Org Chem 64: 2998-2999, 1999.
Holmes et al., Site specific 1:1 opioid: albumin conjugate with in vitro activity and long in vivo duration. Bioconjug Chem 11: 439-444, 2000.
Parr et al., Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention. Histol Histopathol. Jan. 2001;16(1):251-68. Review.
Thomas et al., A peptide sequence on carcinoembryonic antigen binds to a 80kD protein on Kupffer cells. Biochem Biophys Res Commun 188: 671-677, 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptides that specifically bind HGF receptor (CMET) and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides that specifically bind HGF receptor (CMET) and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides that specifically bind HGF receptor (CMET) and uses... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4270360

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.